Tag: lesions

Eluvia DES

Real-world registry shows sustained efficacy for Eluvia DES in the SFA

This advertorial is sponsored by Boston Scientific.  During a satellite symposium session dedicated to real cases and trial outcomes which was held at the Cardiovascular...
LUMIFOLLOW

LUMIFOLLOW one-year outcomes show efficacy for femoropopliteal lesions

Luminor (iVascular) drug-coated balloon (DCB) has confirmed its excellent safety and efficacy in femoropopliteal lesions with new study LUMIFOLLOW, a recent press release states. iVascular...

12-month PRISTINE registry data show efficacy of sirolimus-eluting balloon in the...

Tze Tec Chong (Singapore General Hospital, Singapore) presented results from the PRISTINE registry at this year’s Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2023...
Purple drug-coated balloon in an s shape

Medtronic receives US FDA clearance for 200mm and 250mm IN.PACT Admiral...

Medtronic has announced that it has received US FDA approval for 200mm and 250mm lengths of the IN.PACT Admiral drug-coated balloon (DCB) to treat...
interim

Latest data on Lutonix and IN.PACT drug-coated balloons in AV access...

There in an increasing physician interest in exploring the role of drug-coated balloons in arteriovenous (AV) access. At the Leipzig Interventional Course (LINC; 30...